SNN Stock Analysis: Buy, Sell, or Hold?
SNN - Smith & Nephew plc
$31.59
-0.05 (-0.16%)
▼
5d:
-1.1%
30d:
-14.39%
90d:
-4.39%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When SNN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.86
Based on 3.0% avg growth
INTRINSIC VALUE TODAY
$27.23
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNN is currently trading at $31.59, which is considered oversold relative to its 30-day fair value range of $32.53 to $36.06. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.1) compared to its historical average (18.1). Remarkably, the market is currently pricing in an annual earnings decline of 5.9% over the next few years. This pessimistic expectation contrasts with the company's recent 70.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SNN is in a uptrend. The price is currently testing key support at $31.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $36.62 (+15.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNN is in a uptrend. The price is currently testing key support at $31.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $36.62 (+15.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$32.53 -
$36.06
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($36.62)
Fair Price Analysis
30-Day Fair Range
$32.53 -
$36.06
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$31.62
Resistance Level
$33.52
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.11
Wall Street Target
$36.62
(+15.9%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
70.4%
Profit Margin
10.1%
Valuation Discount vs History
-5.9% cheaper
PE vs Historical
15.1 vs 18.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.9%
(market-implied from PE analysis)
1-Year Target
$29.73
(-6%)
2-Year Target
$27.97
(-12%)
3-Year Target
$26.32
(-17%)
3-Yr Target (if PE normalizes)
(PE: 15→18)
$31.53
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 2.0%)
$49.52
(+57%)
Base:
(SPY PE: 15.1, Growth: 2.0%)
$33.49
(+6%)
Bear:
(PE: 12.8, Growth: 2.0%)
$28.46
(-10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 22.34 | Current EPS (TTM): $1.43
Bull Case
$51.36
(+61%)
Analyst growth 46.2%, PE expands to 24.6
Base Case
$46.69
(+46%)
Market implied 46.2%, PE stable at 22.3
Bear Case
$21.72
(-32%)
Severe decline -20.0%, PE contracts to 19.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.1 to 18.1
Stabilization Target:
$37.83
(+19.8%)
PE Expansion Potential:
+19.8%
Share & Embed Analysis
Last updated: March 31, 2026 3:29 AM ET
Data refreshes hourly during market hours. Next update: 4:29 AM
Data refreshes hourly during market hours. Next update: 4:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 51 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
